Johnson & Johnson Analyst Price Targets - Benzinga

Johnson & Johnson

JNJNYSE

Trade with Public

Trade with Public

$261.49

5.011.95%

最終更新: Oct 9, 7:46 PM

$261.00

4.521.76%

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

© 2026 Benzinga | All Rights Reserved

Johnson & Johnson Analyst Price Targets - Benzinga

Johnson & Johnson Analyst Price Targets

Wall Street analyst price targets and consensus rating for Johnson & Johnson (JNJ).

Price Target Range — 8 Quarters

Analyst Consensus — 17 Analysts

11Buy

6Hold

Consensus RatingBuy# Analysts17Avg. Consensus PT$265Upside to Avg. PT+1.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	Guggenheim	Vamil Divan	Maintained	Buy	$287
Oct 6, 2026	RBC Capital	Trung Huynh	PT Raise	Outperform	$287→$290
Oct 5, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$298→$303
Sep 29, 2026	JP Morgan	Chris Schott	PT Raise	Neutral	$270→$285
Sep 10, 2026	HSBC	Rajesh Kumar	PT Raise	Buy	$290→$320
Sep 2, 2026	UBS	Michael Yee	PT Raise	Buy	$280→$320
Aug 6, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$270→$287
Aug 3, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$272→$282
Jul 17, 2026	Guggenheim	Vamil Divan	Maintained	Buy	$270
Jul 16, 2026	Raymond James	Jayson Bedford	PT Raise	Outperform	$258→$265
Jul 16, 2026	RBC Capital	Shagun Singh	Maintained	Outperform	$287
Jul 16, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$263→$272
Jul 16, 2026	Morgan Stanley	Terence Flynn	PT Raise	Overweight	$284→$294
Jul 13, 2026	TD Cowen	Michael Nedelcovych	PT Raise	Buy	$250→$300
Jul 13, 2026	RBC Capital	Shagun Singh	PT Raise	Outperform	$265→$287
Jul 10, 2026	B of A Securities	Tim Anderson	PT Raise	Neutral	$254→$263
Jul 8, 2026	Morgan Stanley	Terence Flynn	PT Raise	Overweight	$283→$284
Jul 8, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$285→$298
Jun 26, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$266→$270
May 13, 2026	Leerink Partners	David Risinger	Upgrade	Market Perform→Outperform	$265

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Guggenheim Reiterates Buy on Johnson & Johnson, Maintains $287 Price Target

Guggenheim analyst Vamil Divan reiterates Johnson & Johnson (NYSE:JNJ) with a Buy and maintains $287 price target.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $290

RBC Capital analyst Trung Huynh maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and raises the price target from $287 to $290.

Benzinga Newsdesk

Johnson & Johnson Q3 Preview: Analyst Projects In-Line Sales, Earnings Miss

Analysts expect Johnson & Johnson's Q3 FY2027 sales to be in line, but EPS to be below consensus due to IPR&D dilution.

Priya Nigam

PRO
JP Morgan Maintains Neutral on Johnson & Johnson, Raises Price Target to $285

JP Morgan analyst Chris Schott maintains Johnson & Johnson (NYSE:JNJ) with a Neutral and raises the price target from $270 to $285.

Benzinga Newsdesk

PRO
HSBC Maintains Buy on Johnson & Johnson, Raises Price Target to $320

HSBC analyst Rajesh Kumar maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises the price target from $290 to $320.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Johnson & Johnson, Raises Price Target to $320

UBS analyst Michael Yee maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises the price target from $280 to $320.

Benzinga Newsdesk